Related Experiment Video
Updated: Aug 11, 2026

06:24
Minimal Erythema Dose (MED) Testing
Published on: May 28, 2013
Clinical evaluation of the modified Makari skin test in minimal residual malignant disease
Abstract:
The results of a double-blind controlled study of the modified Makari skin test in urological malignancy are described. The study suggests that the test will be useful in the monitoring of primary treatment and in the detection of recurrent malignancy and thus indicates a role for the Makari skin test in minimal residual malignant disease.
More Related Videos
06:31Precision Implementation of Minimal Erythema Dose (MED) Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
Published on: December 19, 2019